grid-line

Allogene Therapeutics

4.4K
Volume
+4%
Growth
exploding

Turn Trends into Views🚀

Type in a topic to instantly see search volume, difficulty and related topics. All for free.

Free insights powered by
About the Topic

Clinical-stage biotechnology company founded in 2017 and headquartered in South San Francisco, CA. The company is pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune diseases, differentiating itself by focusing on off-the-shelf cell therapies. The target demographic includes patients with cancer and autoimmune diseases seeking innovative cell therapy treatments.

Allogene Therapeutics was discovered on May 4th 2023 and it currently has a search volume of 4.4K with a growth of +4%.

Key Indicators
Growth
  • Exploding
  • Regular
  • Peaked
Speed
  • Exponential
  • Constant
  • Stationary
Seasonality
  • High
  • Medium
  • Low
Volatility
  • High
  • Average
  • Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Health & Wellnessscience
Related Topics

Save this topic and build your own trend dashboard.

Available with Exploding Topics Pro, try it now.

Claim Free Trial